Your browser doesn't support javascript.
loading
Effect of scheduled antimicrobial and nicotinamide treatment on linear growth in children in rural Tanzania: A factorial randomized, double-blind, placebo-controlled trial.
DeBoer, Mark D; Platts-Mills, James A; Elwood, Sarah E; Scharf, Rebecca J; McDermid, Joann M; Wanjuhi, Anne W; Jatosh, Samwel; Katengu, Siphael; Parpia, Tarina C; Rogawski McQuade, Elizabeth T; Gratz, Jean; Svensen, Erling; Swann, Jonathan R; Donowitz, Jeffrey R; Mdoe, Paschal; Kivuyo, Sokoine; Houpt, Eric R; Mduma, Estomih.
Afiliação
  • DeBoer MD; Department of Pediatrics, University of Virginia, Charlottesville, Virginia, United States of America.
  • Platts-Mills JA; Division of Infectious Diseases & International Health, University of Virginia, Charlottesville, Virginia, United States of America.
  • Elwood SE; Division of Infectious Diseases & International Health, University of Virginia, Charlottesville, Virginia, United States of America.
  • Scharf RJ; Department of Pediatrics, University of Virginia, Charlottesville, Virginia, United States of America.
  • McDermid JM; Division of Infectious Diseases & International Health, University of Virginia, Charlottesville, Virginia, United States of America.
  • Wanjuhi AW; Division of Infectious Diseases & International Health, University of Virginia, Charlottesville, Virginia, United States of America.
  • Jatosh S; Division of Infectious Diseases & International Health, University of Virginia, Charlottesville, Virginia, United States of America.
  • Katengu S; Haydom Global Health Research Centre, Haydom Lutheran Hospital, Haydom, Tanzania.
  • Parpia TC; Haydom Global Health Research Centre, Haydom Lutheran Hospital, Haydom, Tanzania.
  • Rogawski McQuade ET; Division of Infectious Diseases & International Health, University of Virginia, Charlottesville, Virginia, United States of America.
  • Gratz J; Division of Infectious Diseases & International Health, University of Virginia, Charlottesville, Virginia, United States of America.
  • Svensen E; Division of Infectious Diseases & International Health, University of Virginia, Charlottesville, Virginia, United States of America.
  • Swann JR; Haukeland University Hospital, Bergen, Norway.
  • Donowitz JR; School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Mdoe P; Department of Surgery & Cancer, Imperial College London, London, United Kingdom.
  • Kivuyo S; Division of Infectious Disease, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia, United States of America.
  • Houpt ER; Haydom Global Health Research Centre, Haydom Lutheran Hospital, Haydom, Tanzania.
  • Mduma E; National Institute for Medical Research, Muhimbili Medical Research Centre, Dar es Salaam, Tanzania.
PLoS Med ; 18(9): e1003617, 2021 09.
Article em En | MEDLINE | ID: mdl-34582462
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Desenvolvimento Infantil / Niacinamida / Anti-Infecciosos Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Infant / Newborn / Pregnancy País/Região como assunto: Africa Idioma: En Revista: PLoS Med Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Desenvolvimento Infantil / Niacinamida / Anti-Infecciosos Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Infant / Newborn / Pregnancy País/Região como assunto: Africa Idioma: En Revista: PLoS Med Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos